Image Banner

McKinsey's China Healthcare Summit Report

Download This Exclusive Report

What are the latest trends shaping the biopharma industry in China? The exclusive Building Bridges to Innovation report by McKinsey & Co. was commissioned for the 5th BioCentury-BayHelix China Healthcare Summit (Nov. 13-14, 2018, Shanghai). Based on a survey of industry leaders, the report discusses:

  • Will quality and reimbursement reforms create a “year of reckoning” for mature brands in China?
  • How fast is market access improving in China for innovative products?
  • Has the war for talent in China reached a boiling point?
  • Can local biopharma innovation compete with multinational products in China?
  • How will digitization improve physician and patient engagement in China?
  • Plus: The third edition of McKinsey's China Drug Innovation Index (CDII)

We invite you to download a complimentary copy.


The BioCentury-BayHelix China Healthcare Summit is an annual event organized by BioCentury and BayHelix in collaboration with McKinsey & Co. This year's conference saw record attendance. We hope to see you in 2019! For sponsorship inquiries, please contact


Joshua Berlin
Executive Director & Editor, New Ventures
BioCentury Inc.

We hope that you found this message to be useful. However, if you would rather not receive future emails of this sort from BioCentury, please click here to unsubscribe or to update your preferences.

BioCentury Inc. • P.O. Box 1246 • San Carlos, CA 94070 • +1-650-595-5333
View our Privacy Policy.